Vaxdyn and the University of Latvia have obtained funding from the EUROSTARS program to pr... 22/04/2024 Healthcare Access to innovation Advanced therapies They receive a grant of half a million euros to prepare the clinical and commercial strategy for vaccination against... Partners - Vaxdyn
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Antibiotic resistance Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally... AseBio
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 We consider that improvements have been made regarding the original proposal, but these continue to be insufficient for... AseBio
Webinar: Preparing for IVDR Clinical Performance Studies Online Del 30/04/2024 17:00 to 30/04/2024 18:00 Healthcare Access to innovation In vitro diagnostics Personalized medicine The webinar will focu on the critical aspects of designing and conducting In Vitro Diagnostic (IVD) performance studies...
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications aimed at alleviating... AseBio
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Approximately 10,000 new cases of Parkinson's are detected each year in Spain, with a total figure exceeding 150,000... AseBio
ORYZON announces U.S. FDA clearance of CTEP-CRADA Phase I/II clinical trial sponsored by N... 08/04/2024 Healthcare Access to innovation In combination with either atezolizumab or durvalumab. Partners - Oryzon Genomics
#AseBioID24 | "AseBio Investor Day is a unique meeting point for companies and investors s... 08/04/2024 Healthcare Access to innovation Financing With the aim of analyzing the Spanish biotechnological ecosystem and delving into the challenges and opportunities it... AseBio - Euronext
Revolution in Pain Management straight from Spain: Introducing the Spinally Medical 08/04/2024 Healthcare Access to innovation Spinally Medical introduces FuturaLead™, a subarachnoid device for spinal cord stimulation aimed at patients suffering... Partners
The Spanish AI Healthcare Landscape 04/04/2024 Healthcare Access to innovation Rare diseases Personalized medicine While not yet a global player, Artificial Intelligence (AI) is increasingly being integrated into the healthcare... Partners - OWKIN
